CaroGen Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:CaroGen Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011913
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CaroGen Corp (CaroGen) is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its virus-like vesicle platform technology, a proprietary replication competent to develop nano particle therapeutic vaccines for the treatment of various infectious diseases and cancer. CaroGen’s lead vaccine program is developed for the treatment chronic hepatitis B viral infection. The company’s virus-like vesicle technology generated are capable of entering into cells of the vaccinated subject and are propagated to produce the vaccine antigens. It operates through various researchers and academic partners to assess the efficacy of VLV vaccines and to expand its product portfolio. CaroGen is headquartered in Farmington, Connecticut, the US.

CaroGen Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CaroGen Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CaroGen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CaroGen Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CaroGen Raises USD1 Million in Series A Financing 10
CaroGen Raises USD2 Million in Financing 11
CaroGen Raises US$0.15 Million In Pre-Seed Financing 12
Partnerships 13
CaroGen to Enter into Agreement with GP Healthcare 13
CaroGen Enters into Research Agreement with Yale University 14
Licensing Agreements 15
CaroGen Enters into Licensing Agreement with Yale University 15
CaroGen Corp – Key Competitors 16
CaroGen Corp – Key Employees 17
CaroGen Corp – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CaroGen Corp, Pharmaceuticals & Healthcare, Key Facts 2
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CaroGen Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CaroGen Corp, Deals By Therapy Area, 2011 to YTD 2017 8
CaroGen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CaroGen Raises USD1 Million in Series A Financing 10
CaroGen Raises USD2 Million in Financing 11
CaroGen Raises US$0.15 Million In Pre-Seed Financing 12
CaroGen to Enter into Agreement with GP Healthcare 13
CaroGen Enters into Research Agreement with Yale University 14
CaroGen Enters into Licensing Agreement with Yale University 15
CaroGen Corp, Key Competitors 16
CaroGen Corp, Key Employees 17

★海外企業調査レポート[CaroGen Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hopewell Holdings Ltd:企業の戦略的SWOT分析
    Hopewell Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Salzgitter Klockner-Werke GmbH:企業の戦略・SWOT・財務情報
    Salzgitter Klockner-Werke GmbH - Strategy, SWOT and Corporate Finance Report Summary Salzgitter Klockner-Werke GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Rockcastle Global Real Estate Co Ltd:企業の戦略・SWOT・財務情報
    Rockcastle Global Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Rockcastle Global Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Nationwide Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Dermala Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dermala Inc (Dermala) is a healthcare products manufacturer that offers skin care products. The company offers acne treatment products such as zinc, acne spot treatment, acne pimple patches, advanced probiotics, acne treatment pads, and acne treatment system. It uses the human microbiome and …
  • Coca-Cola Amatil Limited:戦略・SWOT・企業財務分析
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • IFFCO-Tokio General Insurance Co. Ltd.:企業の戦略・SWOT・財務情報
    IFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary IFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • Brooks MacDonald Group PLC (BRK)
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • J.B. Hunt Transport Services, Inc.:企業の戦略・SWOT・財務情報
    J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Midas Group Ltd:企業の戦略・SWOT・財務分析
    Midas Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Midas Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NovaMedica LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaMedica LLC (NovaMedica) is a pharmaceutical company that develops drugs for various therapeutic areas. The company offers drugs in the areas of cardiovascular, central nervous system, dermatology, endocrinology, gynecology, infectious disease, gastrointestinal, pediatric, woman’s health, …
  • DCC plc (DCC):企業の財務・戦略的SWOT分析
    DCC plc (DCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • TheraDiag SA (ALTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • High Arctic Energy Services Inc (HWO):石油・ガス:M&Aディール及び事業提携情報
    Summary High Arctic Energy Services Inc (High Arctic) is an oil and gas company that provides drilling services and equipment for rentals. The company provides services such as drilling services, matting and equipment rentals, snubbing services and nitrogen services. It offers equipment rentals of l …
  • Resources Connection Inc (RECN):企業の財務・戦略的SWOT分析
    Summary Resources Connection Inc (Resources Connection) operates as a consultancy firm that offers consulting and business initiative support services. The firm offers services such as change management, finance and accounting services, merger and acquisition transaction services, program and projec …
  • Banque Cantonale Vaudoise (Private Banking):企業の戦略・SWOT・財務情報
    Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆